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Ethical Issues in  
Human Subjects Research 
Martha Jones, MA, CIP 
Sarah Fowler-Dixon, PhD, CIP 
Some Basics 
• What is research? 
• What is beneficence? 
– What are some potential benefits? 
– What types of risks may exist?  
– How are risks assessed? 
• How is consent handled with minors? 
Think about 
• Is it research? 
– Applicable federal, state and local 
regulations 
• Foreseeable risks and potential 
benefits 
– Are risks reasonable given the potential 
benefits? 
– Are there some risks that are so 
objectionable that they should never be 
authorized regardless of the benefits? 
– Physical, Psychological, Social, Economic 
and Legal risks 
 
Think about 
• Consent and Assent processes 
– What is the relationship between risk 
assessment and informed consent?  
• If the participants are informed does that make the 
risks acceptable? 
– Most appropriate consent/assent for the study 
• Should potential participants be engaged in a 
discussion? 
• Maintaining participant privacy and data 
confidentiality 
• Protections for vulnerable populations 
 
 
Case Example 1 
• A researcher wants to conduct a chart 
review of patients from 1999 to 2006.  
This researcher is interested in 
collecting height, weight, amount of 
blood drawn and reason for blood 
draw. The researcher hopes to 
establish standard practices and 
based on results may want to continue 
the study to affect change in standard 
practices. 
– Is this research? 
Case Example 2  
• A child has been treated unsuccessfully 
over the years and has finally decided 
that he does not want any more 
treatment.  
– What should happen if the parents want to 
enroll the child in a protocol examining a 
promising new treatment that might benefit 
the child, but the child is unwilling to 
assent? 
– Is there a therapeutic misconception in 
play? 
Case Example 3 
• A study wants to conduct allergy skin 
testing on children. There is no direct 
benefit to the children enrolled in this 
study. The children being enrolled are 
considered “healthy, with no known 
allergies.” 
– When do you transition from minimal risk 
to greater than minimal risk? 
– Would one or two parent signatures be 
required? 
Risk Ratings for Minors 
• 46.404; 50.51: Minimal Risk means 
that the probability and magnitude of 
harm or discomfort anticipated in the   
research are not greater in and of 
themselves than those ordinarily 
encountered in daily life or during the 
performance of routine physical or 
psychological examinations or tests. 
– One parent signature 
46.405 
• 46.405; 50.52: The research risk is 
greater than minimal and it presents the 
prospect of direct benefit to the 
participant. 
– One parent signature 
46.406 
• 46.406; 50.53: The research is greater than minimal 
risk with no direct benefit to the minors but it is likely 
to yield generalizable knowledge about the subject’s 
disorder or condition.  And/or, the minors being 
recruited have a disorder or condition that would 
place them in a group other than average healthy 
child therefore, the research is a minor increment 
over minimal risk.  (This risk is slightly more than 
what the average healthy minor would experience but 
is an experience or an expectation given their 
condition.) 
– Two parent signatures 
407 
• 46.407; 50.54: The research uses minors 
that do not have the disease being studied 
and is greater than minimal risk.  It presents 
an opportunity to understand, prevent, or 
alleviate a serious problem affecting the 
health and welfare of minors but presents no 
direct benefits to the participants.  (Please 
note, research in this category must be 
reviewed by the HRPO and then submitted to 
the DHHS Secretary for review by a panel of 
experts.) 
– Two parent signatures 
Reference Material 
 Found at http://hrpohome.wustl.edu. 
• 45 CFR 46, subpart D children 
• 45 CFR 46.404, 46.405, 46.406, 46.407 
• 21 CFR 50.51, 50.52, 50.53, 50.54 
• WU Assent Guideline,  
• WU Consent Guideline 
• WU Wards of State Guideline 
 
Reference Material 
• THE ETHICS AND REGULATION OF 
RESEARCH WITH HUMAN SUBJECTS BY 
CARL H. COLEMAN, JERRY A. MENIKOFF, 
JESSE A. GOLDNER, AND NANCY 
NEVELOFF DUBLER PUBLISHED BY LEXIS 
NEXIS 
 
Bonus Case Example  
• A researcher is interested in studying 
contraceptive choices amongst adolescents. As 
adolescents present to Planned Parenthood, they 
will be given a questionnaire about current 
contraceptive choices and information about 
contraceptives available. The idea is to not only 
gather information about current beliefs and 
choices but also educate adolescents about 
choices. 
 
– Can the minors consent for themselves? 
– What about privacy and confidentiality? 
– What are the risks? 
– What happens if a minor turns out to be a Ward of 
the State? Does this change matters? How? 
 
